Cytek Biosciences Insider Transactions: CFO Increases Holding by 169% in 2025.
ByAinvest
Sunday, Feb 1, 2026 9:24 am ET1min read
CTKB--
Cytek Biosciences insiders were net buyers of the company's stock in the last year, with the largest purchase being by Chief Financial Officer William McCombe, who bought $97k worth of shares at $2.78 per share. Insiders own 9.3% of the company's shares, worth $60m. While the transactions are encouraging, they do not necessarily indicate a bullish outlook for the company.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet